## 



## 

## 



## 

## 

## 

## 

## 




## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 




## 

## 

## 

## 




## 

## 

## 

## 

## 




## 

## 

|STRUCTURE, GOVERNANCE|~|~|~|MANAGEMENT|MANAGEMENT|MANAGEMENT|||||
|---|---|---|---|---|---|---|---|---|---|---|
|Policies and procedures|||||||||||
|A number ofpolices and procedures,||have||been|developed|orreviewed throughout||the year|||
|-Anti-Harassment<br>and Bullying Pohc|||||||||||
|-Articles ofAssociation|||||||||||
|-Chair role description|||||||||||
|-Code ofConduct for Trustees|||||||||||
|- Conflicts ofInterest Policy and dec||laration form|||||||||
|-Equal Opportunities<br>Policy|||||||||||
|-Financial Authority<br>Policy|||||||||||
|-Grievance Policy|||||||||||
|-Media Consent Form|||||||||||
|-MFF GDPR/Data Protection Policy|||||||||||
|-MFF Constitution|||||||||||
|-MFF Risk register|||||||||||
|-Privacy Policy|||||||||||
|-Procedural<br>Standing Orders|||||||||||
|-Recruitment<br>Guide - ofnew trusted||s/volunteers|||||||||
|-Reserves Policy|||||||||||
|- Secretary Role Description|||||||||||
|-Social Media Policy|||||||||||
|-Treasurer Role Description|||||||||||
|-Trustee Board Expenses Policy|||||||||||
|-Trustee Role Descriptions|||||||||||
|-Volunteer Policy|||||||||||
|-Whistleblowing<br>Policy|||||||||||
|Wider network|||||||||||
|The Brighton &Hove Community|W||orks HIV||representative||works closely with|the Martin|Fisher Foundation.||
|Trustees (including<br>attending<br>Board||meetings)|||and advises|on avariety ofissues,||including|community|engagement.|
|REFERENCE AND ADMINISTRA|||TIVEDETAILS||||||||
|Registered Company number|||||||||||
|09773654(England and Wales)|||||||||||





## 



## 





## 

## 



## 

## 

|||||2020|2019|
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
|||fund|funds|funds|funds|
||Notes|||||
|INCOME AND ENDOWMENTS FROM||||||
|Donations<br>and legacies||2,300|23,937|26,237|1,809|
|Other trading activities||7,022|819|7,841|10,297|
|Total||9,322|24,756|34,078|12,106|
|EXPENDITURE ON||||||
|Raising funds||1,903||1,903|7,801|
|Charitable activities||||||
|Project 2Testing||1/24||1,224|2,730|
|Support Costs||1,401||1,401|3,149|
|Stigma project|||||27,048|
|Total||4,528||4,528|407728|
|NET INCOME/(EXPENDITURE)||4,794|24,756|29,550|(28,622)|
|RECONCILIATION OF FUND||||||
|Total funds brought forward||9,076|24,684|33,760|62,382|
|TOTAL FUNDS CARRIED FORWARD||13,870|49,440|63,310|33,760|





## 

|||||2020|.2019|
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
|||fund|funds|funds|funds|
||Notes|||||
|CURRENT ASSETS||||||
|Cash at bank||15+98|50,142|65,440|35,890|
|CREDITORS||||||
|Amounts<br>falling due within one year||(1,428)|(702)|(2,130)|(2,130)|
|NET CURRENT ASSETS||13,870|49,440|63,310|33,760|
|TOTAL ASSETS LESSCURRENT||||||
|LIABILITIES||13,870|49,440|63,310|33,760|
|NKT ASSETS||13,870|49,440|63,310|33,760|
|FUNDS||||||
|Unrestricted<br>funds||||13,870|9,076|
|Restricted funds||||49,440|24,684|
|TOTAL FUNDS||||63,310|33,760|





## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

|2.|DONATION|S<br>AND LEG|ACIES|||
|---|---|---|---|---|---|
|||||2020|2019|
||Donations|||2,300|1,309|
||Grants|||23,937|500|
|||||26,237|1,809|
||Grants received, included||in,the above, are as follows:|||
|||||2020|2019|
||Gilhead Sciences Ltd|||23,937||
||PCC for Sussex||||500|
|||||23,937|500|
|3.|OTHER TRADING AC||TIES|||
|||||2020|2019|
||Fundraising<br>Test kit sales|events||6,672<br>1,169|9,580<br>717|
|||||7,841|10,297|
|4.|NET INCOME/(EXPENDITURE)|||||
||Net income/(expenditure)||iq stated after charging/(crediting):|||
|||||2020|2019|
||Independent|examination||1,080|1,110|





## 

## 

## 

## 

## 

|COMPARATIVES F|ORf|H|E STATEMENT OF FIN|ANCIAL ACTIVITIES|||
|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Total|
|||||fund|funds|funds|
|INCOME AND ENDO~|||NTS FROM||||
|Donations<br>and legacies||||1,809||1,809|
|Other trading activities||||9,581|716|10,297|
|Total||||11,390|716|12,106|
|EXPENDITURE ON|||||||
|Raising funds||||7,801||7,801|
|Charitable<br>activities|||||||
|Project 2 Testing|||||2,730|2,730|
|Support Costs||||3,149||3,149|
|Stigma project|||||27,048|27,048|
|Total||||10,950|29,778|40,728|
|NET INCOME/(EXPEND||ITURE)||440|(29,062)|(28,622)|
|RECONCILIATION|OF FUND||||||
|Total funds brought forwa||rd||8,636|53,746|62,382|
|TOTAL FUNDS CARRIE||D|FORWARD|9,076|24,684|33,760|





## 

## 

|7.|CREDITORS: AMOUNT|SFALLING DUE WITHIN ONE Y|EAR|||
|---|---|---|---|---|---|
|||||2020|2019|
||Accrued expenses|||2,130|2,130|
|8.|MOVEMENT IN FUNDS|||||
|||||Net||
||||At|movement|At|
||||1/10/19|in funds|30/9/20|
||||f,|||
||Unrestricted<br>funds|||||
||General fund||9,076|4,794|13,870|
||Restricted funds|||||
||Project 2 Testing<br>Strategic Development<br>Stigma Project||19,841<br>5,545<br>(702)|24,756|44,597<br>5,545<br>(702)|
||||24,684|24,756|49,440|
||TOTAL FUNDS||33,760|29,550|63,310|
||Net movement<br>in funds, incl|uded in the above are as follows:||||
||||Incoming|Resources|Movement|
||||resources|expended|in funds|
||Unrestricted<br>funds|||||
||General fund||9,322|(4,528)|4,794|
||Restricted funds|||||
||Project 2 Testing||24,756||24,756|
||TOTAL FUNDS||34,078|(4,528)|29,550|





## 

## 

## 

|Comparativcs<br>for movem3|nt in funds||||
|---|---|---|---|---|
||||Net||
|||At|movement|At|
|||1/10/18|in funds|30/9/19|
|Unrestricted<br>funds|||||
|General fund||8,636|440|9,076|
|Restricted funds|||||
|Project 2Testing||21,855|(2,014)|19,841|
|Strategic Development||5,545||5,545|
|Stigma Project||26,346|(27,048)|(702)|
|||53,746|(29,062)|24,684|
|TOTAL FUNDS||62,382|(28,622)|33,760|
|Comparative<br>net movemen)|in funds, included|in the above are as follows:|||
|||Incoming|Resources|Movement|
|||resources|expended|in funds|
|Unrestricted<br>funds|||||
|General fund||11,390|(10,950)|440|
|Restricted funds|||||
|Project 2Testing||716|(2,730)|(2,014)|
|Stigma Project|||(27,048)|(27,048)|
|||716|(29,778)|(29,062)|
|TOTAL FUNDS||12,106|(40,728)|(28,622)|







## 

## 

## 

## 


